Inify Laboratories AB (publ) Stock: price and insider trades · Sweden
1 insider bought shares over the last 90 days, the latest by Magne Jordanger, filed 27 Aug 2026.
Inify Laboratories AB (publ): what insiders have been doing
Every trade that managers of Inify Laboratories AB (publ) disclose to Finansinspektionen is tracked on this page. The company sits in the Health Care sector. Over the twelve months to 3 November 2026, 8 filings were filed, from 3 insiders.
The record shows 2 purchases on the open market worth €12k, made by 2 insiders, against 1 sale by 1 insider. The amount is not disclosed for 2 filings. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Biggest ticket of the year: €12k, bought by Anette Frumerie and made public on 23 May 2026. Among those who bought: 2 board members.
The latest purchase dates back some time: it was published 73 days ago, on 27 August 2026. The median gap between a trade and its publication by Finansinspektionen is 1 day. For comparison, MAR article 19 gives managers three business days to notify a trade.
For context, the typical company on the same exchange (median of 1,032 companies) published 9 filings over the same period, against 8 filings here. Since 2022, the database holds 7 purchases and 1 sale by insiders of the company.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and UCB. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleFinancial data
· cache
- 47,410,660 shares@ €0.7259AktieISIN SE0017486103FI:csv-1dc195d470d901ff8708
- 47,410,660 shares@ €0.7259AktieISIN SE0017486103FI:csv-a1277560d8119528488cCanonical exit: 24 Nov 2026 (T+90)
- 900 shares@ SEK 147.00100.0% of flowAktieISIN SE0001852419FI:A003Z054-1Canonical exit: 19 Aug 2026 (T+90)
- 67,372 shares@ NOK 3.5044.9% of flowAktieISIN SE0017486103FI:csv-db4a9683a31fd03b47e3
- 67,372 shares@ NOK 3.5045.2% of flowAktieISIN SE0017486103FI:csv-e008ab272bc0d7bb7203
- 898,204 shares@ NOK 3.502.2% of flowAktieISIN SE0017486103FI:csv-4405dbb5b7065ada5551
- 17,167,701 shares@ NOK 3.5083.7% of flowAktieISIN SE0017486103FI:A003U911-1
- 3,347,788 shares@ NOK 3.507.8% of flowAktieISIN SE0017486103FI:A003U910-1
- 9,500 shares@ NOK 5.509.8% of flowAktieISIN SE0017486103FI:A003R844-1Canonical exit: 26 Nov 2025 (T+90)
- 6,840 shares@ SEK 4.1939.0% of flowAktieISIN SE0017486103FI:csv-54cc554f6b23cad91107Canonical exit: 27 Apr 2025 (T+90)
- 10,000 shares@ SEK 4.4861.0% of flowAktieISIN SE0017486103FI:csv-a1ca14f171ef89d6b877Canonical exit: 29 Apr 2025 (T+90)
- 2,034,376 shares@ NOK 4.506.2% of flowAktieISIN SE0017486103FI:csv-3a3d7ec1f93349089901
- 20,229,274 shares@ NOK 4.5061.9% of flowAktieISIN SE0017486103FI:csv-323dc8a1d058c6eaacce
- 5,022,570 shares@ NOK 4.5015.4% of flowAktieISIN SE0017486103FI:csv-fe81d31d59b81ec30bbc
- 650,000 shares@ NOK 10.004.5% of flowAktieISIN SE0017486103FI:csv-19a1907fb6757bf67556Canonical exit: 3 Oct 2023 (T+90)
- 336,950 shares@ NOK 7.602.1% of flowAktieISIN SE0017486103FI:csv-9f8599220941dbca23b7Canonical exit: 17 Nov 2022 (T+90)
16 of 16 declarations
About Inify Laboratories AB (publ)
Inify Laboratories AB (publ) is a Swedish company focused on developing diagnostic solutions for the healthcare sector. It is listed on the XSTO exchange.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
